| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.086 | 0.05 |
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.21 | 0.05 |
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.05 |
| mRNA | T0901317 | GDSC1000 | pan-cancer | AAC | 0.061 | 0.06 |
| mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | -0.074 | 0.06 |
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.06 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | -0.063 | 0.06 |
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | -0.061 | 0.06 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.06 |
| mRNA | phloretin | CTRPv2 | pan-cancer | AAC | 0.063 | 0.07 |